NASDAQ:ARCT

Arcturus Therapeutics Holdings Stock Forecast

etoro logo Buy ARCT
*Your capital is at risk
$7.30
-0.740 (-9.20%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of ARCT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ARCT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Arcturus Therapeutics Holdings Inc. stock price on Friday moving 10.93% between high and low
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 05, 2026

The Arcturus Therapeutics Holdings Inc. stock price fell by -9.20% on the last day (Friday, 5th Jun 2026) from $8.04 to $7.30. During the last trading day the stock fluctuated 10.93% from a day low at $7.23 to a day high of $8.02. The price has risen in 5 of the last 10 days and is up by 3.99% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -703 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.84 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 9.13% during the next 3 months and, with a 90% probability hold a price between $7.46 and $10.32 at the end of this 3-month period.

ARCT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Arcturus Therapeutics Holdings Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $7.74 and $8.10. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -9.20%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Arcturus Therapeutics Holdings Inc. stock

Arcturus Therapeutics Holdings Inc. finds support from accumulated volume at $7.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.790 between high and low, or 10.93%. For the last week the stock has had daily average volatility of 6.35%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARCT) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Arcturus Therapeutics Holdings Inc. to open at $7.52, and during the day (based on 14 day Average True Range), to move between $7.05 and $7.55, which gives a possible trading interval of +/-$0.493 (+/-6.99%) up or down from last closing price. If Arcturus Therapeutics Holdings Inc. takes out the full calculated possible swing range there will be an estimated 6.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $7.03 (3.70%) than the resistance at $7.72 (5.75%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Arcturus Therapeutics Holdings Inc. stock A Buy?

The Arcturus Therapeutics Holdings Inc. stock holds several negative signals and despite the positive trend, we believe Arcturus Therapeutics Holdings Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.375 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $7.52 ( 2.97%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ARCT Performance

Trading levels for ARCT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 8.31 13.79%
R2 8.00 9.66%
R1 7.82 7.10%
Price 7.30
S1 7.21 -1.17%
S2 7.03 -3.72%
S3 6.73 -7.85%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.62 18.08%
R2 7.85 7.53%
R1 7.72 5.75%
Price 7.30
S1 7.03 -3.70%
S2 6.63 -9.18%
S3 6.39 -12.47%

ARCT Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 27, 2012 Jan 08, 2013 Jan 15, 2013 $0.0596 0%
2 Dec 28, 2012 Jan 04, 2013 Jan 15, 2013 $0.0596 0%
3 Nov 28, 2012 Dec 05, 2012 Dec 15, 2012 $0.0600 0%
4 Oct 26, 2012 Nov 06, 2012 Nov 15, 2012 $0.0600 0%
5 Sep 27, 2012 Oct 03, 2012 Oct 15, 2012 $0.0600 0%

FAQ

What is the symbol for Arcturus Therapeutics Holdings Inc. Stock and on which exchange is it traded?
The symbol for Arcturus Therapeutics Holdings Inc. is ARCT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Arcturus Therapeutics Holdings Inc. Stock?
The Arcturus Therapeutics Holdings Inc. stock holds several negative signals and despite the positive trend, we believe Arcturus Therapeutics Holdings Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Arcturus Therapeutics Holdings Inc. Stock?
Arcturus Therapeutics Holdings Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arcturus Therapeutics Holdings Inc. Stock.

What's the current price of Arcturus Therapeutics Holdings Inc. Stock?
As of the end of day on the Jun 05, 2026, the price of an Arcturus Therapeutics Holdings Inc. (ARCT) share was $7.30.

What is the 52-week high and low for Arcturus Therapeutics Holdings Inc. Stock?
The 52-week high for Arcturus Therapeutics Holdings Inc. Stock is $24.08 and the 52-week low is $5.85.

What is the market capitalization of Arcturus Therapeutics Holdings Inc. Stock?
As of the Jun 05, 2026, the market capitalization of Arcturus Therapeutics Holdings Inc. is 207.488M.

When is the next earnings date for Arcturus Therapeutics Holdings Inc.?
The upcoming earnings date for Arcturus Therapeutics Holdings Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT ARCTURUS THERAPEUTICS HOLDINGS INC.
Arcturus Therapeutics Holdings
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as we...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE